Clinical Trial Update: Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma [Phase 2]

View source ↗

Summary

This update reports a phase 2 salvage therapy trial of idarubicin for relapsing primary central nervous system lymphoma, sponsored by IELSG, which was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Central Nervous System Lymphoma

Drugs mentioned

• Idamycin (idarubicin)

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Lymphoma, B-Cell | Phase 2 | Status: TERMINATED